Registro:

Referencias:

• (2016) Global Tuberculosis Report, , http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1
• Getahun, H., Gunneberg, C., Granich, R., Nunn, P., HIV infection-associated tuberculosis: The epidemiology and the response (2010) Clin. Infect. Dis., 50, pp. S201-S207
• Wu, B., Epidemiology of tuberculosis in chongqing, China: A secular trend from 1992 to 2015 (2017) Sci. Rep., 7, p. 7832
• Suarez, G.V., Immunoendocrine interactions during HIV-TB coinfection: Implications for the design of new adjuvant therapies (2015) Biomed Res. Int., 2015
• Nusbaum, R.J., (2016) Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1. 6, p. 21522
• Chrousos, G.P., The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation (2007) N. Engl. J. Med., p. 332
• Correa, S.G., Cytokines and the immune-neuroendocrine network: What did we learn from infection and autoimmunity? (2007) Cytokine Growth Factor Rev., 18, pp. 125-134
• George, M.M., Bhangoo, A., Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis (2013) Rev. Endocr. Metab. Disord., 14, pp. 105-112
• Chrousos, G.P., Zapanti, E.D., Hypothalamic-pituitary-adrenal axis in HIV infection and disease (2014) Endocrinology and Metabolism Clinics of North America, , https://doi.org/10.1016/j.ecl.2014.06.002l
• Rey, A.D., Endocrine and cytokine responses in humans with pulmonary tuberculosis (2007) Brain. Behav. Immun., 21, pp. 171-179
• Bottasso, O., Bay, M.L., Besedovsky, H., Del Rey, A., Adverse neuro-immune-endocrine interactions in patients with active tuberculosis (2013) Mol. Cell. Neurosci., 53, pp. 77-85
• Quiroga, M.F., Dynamics of adrenal steroids are related to variations in Th1 and treg populations during mycobacterium tuberculosis infection in HIV positive persons (2012) PLoS One, 7, p. e33061
• Pérez, A.R., Bottasso, O., Savino, W., The impact of infectious diseases upon neuroendocrine circuits (2009) Neuroimmunomodulation, 16, pp. 96-105
• Kamin, H.S., Kertes, D.A., Cortisol and DHEA in development and psychopathology (2016) Horm. Behav., 89, pp. 69-85
• Pluchino, N., Neurobiology of DHEA and effects on sexuality, mood and cognition (2015) J. Steroid Biochem. Mol. Biol., 145, pp. 273-280
• Eberling, P., Koivisto, V.A., Physiological importance of dehydroepiandrosterone (1994) Lancet, 343, pp. 1479-1481
• Loria, R., Ben-Nathan, D., Protective effects of DHEA and AED against viral, bacterial and parasitic infections (2011) Isr. J. Vet. Med., 66, pp. 119-129
• Suzuki, T., Suzuki, N., Daynes, R.A., Engleman, E.G., Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells (1991) Clin. Immunol. Immunopathol., 61, pp. 202-211
• Romanutti, C., In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus (2009) Vet. J., 182, pp. 327-335
• Torres, N.I., In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1 (2012) Antiviral Res., 95, pp. 37-48
• Ramírez, J.A., Syntheses of immunomodulating androstanes and stigmastanes: Comparison of their TNF-A inhibitory activity (2007) Bioorganic Med. Chem., 15, pp. 7538-7544
• Angerami, M., Modulation of the phenotype and function of mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids (2013) Int. Immunol., 25, pp. 405-411
• Suarez, G.V., HIV-TB coinfection impairs CD8+ T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses (2015) Eur. J. Immunol., 45, pp. 2529-2541
• Traish, A.M., Kang, P., Farid Saad, D., Guay, A.T., Dehydroepiandrosterone (DHEA)-A precursor steroid or an active hormone in human physiology (CME) (2011) C., 8, pp. 2960-2982
• Hernandez-Pando, R., The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice (1998) Immunology, 95, pp. 234-241
• Ben-Nathan, D., Padgett, D.A., Loria, R.M., Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity (1999) J. Med. Microbiol., 48, pp. 425-431
• Padgett, D.S., Loria, R.M., Endocrine regulation of murine macrophage function: Effects of dehydroepiandrosterone, androstenediol, and androstenetriol (1998) J. Neuroimmunol., 84, pp. 61-68
• Loria, R.M., Conrad, D.H., Huff, T., Carter, H., Ben-Nathan, D., Androstenetriol and androstenediol protection against lethal radiation and restoration of immunity after radiation injury (2000) Ann. New York Acad. Sci., 917, pp. 860-867
• El Kihel, L., Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)-recent reports (2012) Steroids, 77, pp. 10-26
• Shi, J., Schulze, S., Lardy, H.A., The effect of 7-oxo-DHEA acetate on memory in young and old C57BL/6 mice (2000) Steroids, 65, pp. 124-129
• Mo, Q., Lu, S., Simon, N.G., Dehydroepiandrosterone and its metabolites: Differential effects on androgen receptor trafficking and transcriptional activity (2006) J. Steroid Biochem. Mol. Biol., 99, pp. 50-58
• Miller, K.K.M., DHEA metabolites activate estrogen receptors alpha and beta (2013) Steroids, 78, pp. 15-25
• Marwah, P., Marwah, A., Lardy, H.A., Miyamoto, H., Chang, C., C19-steroids as androgen receptor modulators: Design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists (2006) Bioorg. Med. Chem., 14, pp. 5933-5947
• González, G.A., Herrador, A.M., A practical guide to analytical method validation, including measurement uncertainty and accuracy profiles (2007) Trends Anal. Chem., 26, pp. 227-238
• (2001) Guidance for Industry: Bioanalytical Method Validation, , https://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf
• Hu, S., Conversion of fructose to 5-hydroxymethylfurfural using ionic liquids prepared from renewable materials (2008) Green Chem., 10, p. 1280
• Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M., Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS (2003) Anal. Chem., 75, pp. 3019-3030
• Bloem, L.M., Advances in the analytical methodologies: Profiling steroids in familiar pathways-challenging dogmas (2015) J. Steroid Biochem. Mol. Biol., 153, pp. 1-13
• Jeanneret, F., Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations (2015) J. Chromatogr. A, , https://doi.org/10.1016/j.chroma.2015.07.008
• El-Khoury, M.J., Wang, S., Liquid chromatography-tandem mass spectrometry in the clinical laboratory (2013) J. Chromatogr. Sep. Tech., 4, p. 1000e115
• Methlie, P., Multisteroid LC-MS/MS assay for glucocorticoids and androgens, and its application in Addison's disease (2013) Endocr. Connect, 2, pp. 125-136
• Pauwels, S., Sensitive routine liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone without derivatization (2013) Anal. Bioanal. Chem., 405, pp. 8569-8577
• Gao, W., Stalder, T., Kirschbaum, C., Quantitative analysis of estradiol and six other steroid hormones in human saliva using a high throughput liquid chromatography-tandem mass spectrometry assay (2015) Talanta, 143, pp. 353-358
• Abdel-Khalik, J., Björklund, E., Hansen, M., Simultaneous determination of endogenous steroid hormones in human and animal plasma and serum by liquid or gas chromatography coupled to tandem mass spectrometry (2013) J. Chromatogr. B, 928, pp. 58-77
• Sosvorova, L., Vitku, J., Chlupacova, T., Mohapl, M., Hampl, R., Determination of seven selected neuro- and immunomodulatory steroids in human cerebrospinal fluid and plasma using LC-MS/MS (2015) Steroids, 98, pp. 1-8
• Ke, Y., Bertin, J., Gonthier, R., Simard, J.-N., Labrie, F., A sensitive, simple and robust LC-MS/MS method for the simultaneous quantification of seven androgen- and estrogen-related steroids in postmenopausal serum (2014) J. Steroid Biochem. Mol. Biol., 144, pp. 523-534
• Minkler, P., Hoppel, C., Separation and characterization of cardiolipin molecular species by reverse-phase ion pair highperformance liquid chromatography-mass spectrometry (2010) J Lipid Res, 51, pp. 856-865
• Huan, T., MyCompoundID MS/MS search: Metabolite identification using a library of predicted fragment-ion-spectra of 383,830 possible human metabolites (2015) Anal. Chem., 87, pp. 10619-10626
• Taylor, P.J., Matrix effects: The achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry (2005) Clin. Biochem., 38, pp. 328-334
• Imrie, G.A., Lough, W.J., Noctor, T.A.G., Drug bioanalysis by LC-MS: Some pragmatic solutions to commonly occurring problems (2009) Chromatogr. Today, pp. 27-30
• Li, W., Cohen, L.H., Quantitation of endogenous analytes in biofluid without a true blank matrix (2003) Anal. Chem., 75, pp. 5854-5859
• Jemal, M., Schuster, A., Whigan, D.B., Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: Method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable (2003) Rapid Commun. Mass Spectrom., 17, pp. 1723-1734
• Wudy, S.A., Synthetic procedures for the preparation of deuterium-labeled analogs of naturally occurring steroids (1990) Steroids, 55, pp. 463-471
• Galuska, C.E., Profiling intact steroid sulfates and unconjugated steroids in biological fluids by liquid chromatography-tandem mass spectrometry (LC-MS-MS) (2013) Analyst, 138, pp. 3792-3801
• Landvatter, S.W., Comparison of Deuterium, 13C, and 15N Isotopic Labels in Mass Spec Standards
• Kolatorova Sosvorova, L., Sarek, J., Vitku, J., Kvasnica, M., Synthesis of 3α-deuterated 7α-hydroxy-DHEA and 7-oxo-DHEA and application in LC-MS/MS plasma analysis (2016) Steroids, 112, pp. 88-94
• Marwah, A., Marwah, P., Lardy, H., High-performance liquid chromatographic analysis of dehydroepiandrosterone (2001) J. Chromatogr. A, 935, pp. 279-296
• Prabu, S.L., Suriyaprakash, T., Extraction of drug from the biological matrix: A review (2012) Appl. Biol. Eng. Pract., pp. 479-507. , https://doi.org/10.1333/s00897970137a
• Rasheed, S., Yan, J.S., Lau, A., Chan, A.S., HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: A proteomics study (2008) PLoS One, p. 3
• Ogunro, P.S., Idogun, E.S., Ogungbamigbe, T.O., Ajala, M.O., Olowu, O.A., Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease (2008) Niger. Postgrad. Med. J., 15, pp. 219-224
• Bottasso, O., Bay, M.L., Besedovsky, H., Del Rey, A., The immuno-endocrine component in the pathogenesis of tuberculosis (2007) Scand. J. Immunol., 66, pp. 166-175
• Song, S.H., Proteomic profiling of serum from patients with tuberculosis (2014) Ann. Lab. Med., 34, pp. 345-353
• Seddon, J., Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis (2013) J. Infect. Dis., 208, pp. 1571-1578
• Achkar, J.M., Host protein biomarkers identify active tuberculosis in HIV uninfected and co-infected individuals (2015) EBioMedicine, 2, pp. 1160-1168
• Bongiovanni, B., Changes in the immune and endocrine responses of patients with pulmonary tuberculosis undergoing specific treatment (2012) Ann. N. Y. Acad. Sci., 1262, pp. 10-15
• Lo, J., Grinspoon, S.K., Adrenal function in HIV infection (2010) Curr. Opin. Endocrinol. Diabetes. Obes., 17, pp. 205-209
• Bons, J., Moreau, L., Lefebvre, H., Adrenal disorders in human immunodeficiency virus (HIV) infected patients (2013) Ann. Endocrinol. (Paris)., 74, pp. 508-514
• Findling, J.W., Longitudinal evaluation of function in patients infected with the human immunodeficiency virus (1994) J. Clin. Endocrinol. Metab., 79, pp. 1091-1096
• Treitinger, A., Lipid and acute-phase protein alterations in HIV-1 infected patients in the early stages of infection: Correlation with CD4+ lymphocytes (2001) Braz. J. Infect. Dis., 5, pp. 192-199
• Siddique, M.A., Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune eesponses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy (2006) J. Infect. Dis., 194, pp. 661-665
• Manosuthi, W., Chottanapand, S., Thongyen, S., (2006) Survival Rate and Risk Factors of Mortality among HIV/tuberculosis-coinfected Patients with and Without Antiretroviral Therapy, 43, pp. 42-46
• Achhra, A.C., Petoumenos, K., Law, M.G., Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals (2014) Curr. Opin. HIV AIDS, 9, pp. 63-71
• Santos, A.C.O., Almeida, A.M.R., Nutritional status and CD4 cell counts in patients with HIV/AIDS receiving antiretroviral therapy (2013) Rev. Soc. Bras. Med. Trop., 46, pp. 698-703
• Diedrich, C.R., Flynn, J.L., HIV-1/Mycobacterium tuberculosis coinfection immunology: How does HIV-1 exacerbate tuberculosis? (2011) Infect. Immun., 79, pp. 1407-1417
• Kaufmann, S.H.E., Cole, S.T., Mizrahi, V., Rubin, E., Nathan, C., Mycobacterium tuberculosis and the host response (2005) J. Exp. Med., 201, pp. 1693-1697
• Lawn, S.D., Tuberculosis and HIV co-infection (2005) Medicine (Baltimore)., 33, pp. 112-113
• Yang, Z., Identification of risk factors for extrapulmonary tuberculosis (2004) Clin Inf Dis, 38, pp. 199-205
• Castilla, J., Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: Epidemiological differences and implications for control (1997) AIDS, 11, pp. 1583-1588
• Van De-Beek, D., De Gans, J., McIntyre, P., Prasad, K., Steroids in adults with acute bacterial meningitis: A systematic review (2004) Lancet Infect. Dis., 4, pp. 139-143
• Matchaba, P.T., Volmink, J., Steroids for treating tuberculous pleurisy (review) (2000) Cochrane Database Syst. Rev., p. CD001876. , https://doi.org/10.1002/14651858.CD001876
• Dhama, K., Effect of immunomodulation and immunomodulatory agents on health with some bioactive principles, modes of action and potent biomedical applications (2015) International Journal of Pharmacology, 11, pp. 253-290
• Liu, X.-K., Synthesis and antitumor activity of dehydroepiandrosterone derivatives on Es-2, A549, and HepG2 cells in vitro (2012) Chem. Biol. Drug Des., 79, pp. 523-529
• Silvestre, S.M., Salvador, J.A.R., Allylic and benzylic oxidation reactions with sodium chlorite (2007) Tetrahedron, 63, pp. 2439-2445
• Astná, E., Erný, I., Pouzar, V., Chodounská, H., Stereoselectivity of sodium borohydride reduction of saturated steroidal ketones utilizing conditions of luche reduction (2010) Steroids, 75, pp. 721-725
• (2016) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents, , http://www.aidsinfo.nih.gov/ContentFiles/Adul-tandAdolescentGL.pdf
• Shabir, G.A., (2006) Step-by-step Analytical Methods Validation and Protocol in the Quality System Compliance Industry, pp. 4-14. , https://pdfs.semanticscholar.org/6871/8039ed36445c5e02c1100f21632f6858eff1.pdf
• Shabir, G., A practical approach to validation of HPLC methods under current good manufacturing practices (2004) J. Valid. Technol., pp. 29-37
• Taverniers, I., De Loose, M., Van Bockstaele, E., Trends in quality in the analytical laboratory. II. Analytical method validation and quality assurance (2004) TrAC Trends Anal. Chem., 23, pp. 535-552
• Jurado, J., (2008) Aplicacion de Microsoft Excel A la Quimica Analitica: Validacion de Metodos Analiticos, , http://personal.us.es/jmjurado/docs/AQAEXCEL.pdf
• Marwah, A., Marwah, P., Lardy, H., Analysis of ergosteroids: VIII: Enhancement of signal response of neutral steroidal compounds in liquid chromatographic-electrospray ionization mass spectrometric analysis by mobile phase additives (2002) J. Chromatogr. A, 964, pp. 137-151

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------